Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikrein-related peptidase 5 (KLK5) is a serine protease primarily expressed in the epidermis and plays a crucial role in skin barrier formation and desquamation. It processes profilaggrin to filaggrin, an essential protein for epidermal differentiation and barrier integrity. KLK5 can activate other kallikreins, initiating a proteolytic cascade important for tissue homeostasis and repair. Dysregulation of KLK5 is associated with skin diseases like Netherton syndrome and has potential as a biomarker for ovarian cancer.
Proteolytic cleavage of proteins involved in skin barrier function and desquamation; activation of other kallikreins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein-related peptidase 5 (KLK5).